While vaccines to prevent Human Papillomavirus (HPV) infection have proven to be extremely effective both in protecting against HPV, as well as reducing the risk of cervical cancer caused by HPV strains, acceptance of this cancer-preventing vaccine has struggled to reach the same level of acceptance as other vaccines recommended at this age. Providers have a unique opportunity to address vaccine hesitancy and reinforce the decision to vaccinate.
Join Jennifer Sienko, MPH, Directof of the National HPV Vaccination Roundtable, for her webinar with the objective to:
- Understand the processes that help make vaccine acceptance the "default choice."
- Understand the continuum of vaccine acceptance.
- Describe the main reasons for vaccine hesitancy.
- Learn a response strategy for addressing parental vaccine hesitancy.
CLICK HERE to register now!